AGMB · Agomab Therapeutics NV
Market Cap
$648.60M
Shares
49.25M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-29 | 905 | $12.54 | $11,349 |
| 2026-07-28 | 1,063 | $12.51 | $13,298 |
| 2026-07-27 | 977 | $12.51 | $12,222 |
| 2026-07-24 | 1,653 | $12.97 | $21,439 |
| 2026-07-23 | 469 | $11.60 | $5,440 |
| 2026-07-21 | 437 | $11.98 | $5,235 |
| 2026-07-20 | 245 | $12.04 | $2,950 |
| 2026-07-16 | 447 | $12.63 | $5,646 |
| 2026-07-15 | 28 | $12.04 | $337 |
| 2026-07-14 | 4 | $12.31 | $49 |
| 2026-07-13 | 114 | $13.08 | $1,491 |
| 2026-07-10 | 100 | $13.03 | $1,303 |
| 2026-07-09 | 385 | $12.74 | $4,905 |
| 2026-07-08 | 20 | $13.28 | $266 |
| 2026-07-07 | 209 | $13.52 | $2,826 |
| 2026-07-06 | 3,031 | $12.65 | $38,342 |
| 2026-07-02 | 1,100 | $11.87 | $13,057 |
| 2026-06-30 | 23,666 | $17.82 | $421,728 |
| 2026-06-29 | 2,357 | $13.81 | $32,550 |
| 2026-06-26 | 510 | $13.43 | $6,849 |
| 2026-06-25 | 3,743 | $12.68 | $47,461 |
| 2026-06-23 | 1,154 | $11.84 | $13,663 |
| 2026-06-22 | 2,193 | $10.98 | $24,079 |
| 2026-06-18 | 309 | $10.10 | $3,121 |
| 2026-06-17 | 113 | $10.00 | $1,130 |
| 2026-06-16 | 4,143 | $10.00 | $41,430 |
| 2026-06-15 | 1,210 | $9.61 | $11,628 |
| 2026-06-12 | 1,046 | $9.88 | $10,334 |
| 2026-06-11 | 369 | $10.33 | $3,812 |
| 2026-06-09 | 7,275 | $10.31 | $75,005 |
| 2026-06-08 | 22,955 | $9.92 | $227,714 |
| 2026-06-05 | 429 | $11.89 | $5,101 |
| 2026-06-04 | 1,227 | $12.00 | $14,724 |
| 2026-06-03 | 15,559 | $11.80 | $183,596 |
| 2026-06-02 | 4,008 | $11.44 | $45,852 |
| 2026-06-01 | 2,741 | $11.25 | $30,836 |
Showing 1–36 of 36 settlements
Key facts
CIK
2020932
CUSIP
00860C102
13F (30d)
28 filings
28 filers
Visit website
Investor relations